5N Plus entered into equity investment and partnership agreement with Global Health Sciences (GHS) Fund (Quark Venture LP and GF Securities) backed Microbion Corporation Continue Reading
Arsenal Capital Partners backed Caprion-HistoGeneX acquired Clinical Logistics Inc. from Aka Char and Raymond MahContinue Reading
Global Health Sciences (GHS) Fund, Biosciences Managers, Kobuck, Relentless Venture Fund backed Canary Medical secured US $20M venture loan facility from Horizon Technology Finance Corporation and Silicon Valley BankContinue Reading
Optimi Health Corp. filed preliminary prospectus for IPO on CSE for gross proceeds of up to $15MContinue Reading
Functional mushroom superfood maker, Rritual Superfoods, filed for $4M initial public offering to list on the Canadian Securities Exchange (CSE).Continue Reading
Green Shield Canada (GSC), Manulife Capital and TELUS/TELUS Ventures backed MindBeacon Holdings upsized proposed IPO on TSX from $50M to $65M (8,125,000 common shares @$8.00)Continue Reading
Ripple Therapeutics secured licensing agreement with Théa Open Innovation (TOI) and $14.8M Series A tranche led by TOI with participation of BDC Capital and management. Colin Francou and François Lontrade from TOI/Laboratoires Théa will join Ripple Therapeutics boardContinue Reading
PanTHERA CryoSolutions raised US $2M seed funding from BioLife Solutions and Casdin Capital. Dr. Aby J. Mathew of BioLife and Shaun Rodriguezof Casdin will join Dr. Robert Ben and Dr. Jason Acker on PanTHERA board.Continue Reading
Qu Biologics Inc. has completed an $8 million bridge round of financing with investments from Canadian, US, European and Asian investors.Continue Reading
Lisbon, Portugal based medical cannabis company Southern Harvest to go public by way of initial public offering (IPO) on CSE.Continue Reading
Green Shield Canada, Manulife Capital and TELUS/TELUS Ventures backed MindBeacon Holdings filed for $50M IPO on TSXContinue Reading
DCVC Bio, Viking Global Investors, OrbiMed, Baker Brothers, Founders Fund, Eli Lilly backed AbCellera Biologics to raise up to US $391M (23M shares at US $14-17/share) from NASDAQ IPO. Dr. Carl L. G. Hansen’s stake worth up to US $1.04BContinue Reading
Kenota Health secured $9M Series A from Draper Associates, BDC Capital, Y Combinator, OS Fund, BoxOne Ventures, Dr. Collin Terpstra, 1517, Fifty Years CapitalContinue Reading
Arlington Capital Partners acquired majority stake in Markham, Ontario based full-service CRO Everest Clinical Research Corporation from Irene Zhang and other shareholders. Continue Reading
DCVC Bio, OrbiMed, Viking Global Investors, Baker Brothers, Peter Thiel/Founders Fund, Eli Lilly, Harvard, University of Minnesota backed AbCellera Biologics Inc. filed for initial public offering (IPO) on NASDAQContinue Reading
Canada Pension Plan Investment Board (CPP Investments) to invest US $100M in Hutchison China MediTech Limited (和黃醫藥) for 2.3% stake. CK Hutchison Holdings Limited continues to own 45.7% stakeContinue Reading
iGan Partners backed Think Research Corporation (TRC) entered definitive agreement to go public by way of QT at $120M valuation, TRC to complete $30M concurrent financing priced at $4.65 Continue Reading
